DAM
ETTX

Deltec Asset Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Deltec Asset Management’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-155,614
Closed -$342K – 256
2022
Q2 		$342K Buy
+155,614
New +$311K 0.08% 186

Deltec Asset Management's ETTX Position: Q3 2022 in Review

Deltec Asset Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 155,614 shares — an estimated $342K sold.

Deltec Asset Management first reported a position in ETTX in Q2 2022 and held it in 1 quarter. The position peaked at $342K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • Deltec Asset Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • Deltec Asset Management sold 155,614 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $342K.
  • Deltec Asset Management first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2022 and held it in 1 quarter.
  • Deltec Asset Management's Entasis Therapeutics Holdings Inc. position peaked at $342K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Deltec Asset Management's 13F filing for Q3 2022, filed 26 Oct 2022.